What question did this study set out to answer?

This research aims to evaluate the effectiveness and safety of long-acting cabotegravir and rilpivirine in HIV treatment.

March 28, 2026HIV Medicine0 citations

Use of long‐acting cabotegravir and rilpivirine in people living with HIV : A prospective observational cohort study

This research aims to evaluate the effectiveness and safety of long-acting cabotegravir and rilpivirine in HIV treatment.
Prospective observational cohort design
Participants living with HIV
Monitoring of treatment outcomes and safety
Comparison to standard treatment approaches
CAB+RPV LA shows effectiveness as a treatment option
Safety profiles similar to other therapies
Durability of treatment outcomes observed over the study period

CAB+RPV LA appears to be an effective, safe and durable option for a switch strategy.

AI에게 질문

Bookmark

View Full Paper

AI에게 질문

Bookmark

View Full Paper